mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.5 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |